Par Pharmaceutical Recalls HydrALAZINE Tablets Due to Aluminum Particles
Par Pharmaceutical is recalling one lot of HydrALAZINE Hydrochloride tablets because small aluminum particles were found in the product.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: The recall is classified as FDA Class II, and the hazard involves a foreign substance (aluminum particles) without reported injuries or illnesses, fitting the criteria for a moderate severity precautionary recall.
Plain-English summary
Par Pharmaceutical, Inc. is recalling one lot of HydrALAZINE Hydrochloride tablets, USP 25 mg, 100 count bottles. The recall is due to the presence of small aluminum particles in the tablets.
The affected product is distributed nationwide. The specific lot number is 26708501, with an expiration date of 01/17. The total quantity involved is 38,788 bottles.
Consumers and healthcare providers should check their inventory for this specific lot number and expiration date. If found, the product should be returned to the pharmacy or distributor for a refund or replacement.
The recalled product
- Product
- HydrALAZINE Hydrochloride Tablets, USP 25 mg, 100 count bottle Rx only, Distributed by: Par Pharmaceutical Companies, Inc. Spring Valley, NY10977
- Manufacturer
- Par Pharmaceutical Inc.
- Category
- Drug — Tablets
- Hazard
- Affected units
- 38,788
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot 26708501
- Exp. 01/17
Distribution
Distributed nationwide across the United States.
Related recalls
Same manufacturer · Par Pharmaceutical Inc.
See all →- SeverePar Pharmaceutical Recalls BusPIRone Hydrochloride Tablets Due to Impurity Failure
FDA (Drugs) · 2020-09-02
- SeverePar Pharmaceutical Recalls Glycopyrrolate Tablets Due to Unknown Impurity
FDA (Drugs) · 2020-04-08
- LowPar Pharmaceutical Recalls Prednisone Tablets Due to Incorrect Expiration Date
FDA (Drugs) · 2020-03-25
- LowPar Pharmaceutical Recalls Frovatriptan Tablets Due to Incorrect Expiration Date
FDA (Drugs) · 2020-02-19
- SeverePar Pharmaceutical Recalls Mycophenolate Mofetil Injection Due to Glass Fragment
FDA (Drugs) · 2019-05-15
Same hazard · foreign substance
See all →- ModerateHeritage Pharmaceuticals Recalls Clindamycin Palmitate Hydrochloride Due to Foreign Particles
FDA (Drugs) · 2026-08-19
- HighPrednisolone Acetate Ophthalmic Suspension Recalled for Foreign Substance
FDA (Drugs) · 2026-07-08
- ModerateCorlanor Ivabradine Tablets Recalled for Foreign Substance Contamination
FDA (Drugs) · 2026-07-01
- LowHydroxyzine Hydrochloride Oral Solution recalled for foreign substance
FDA (Drugs) · 2026-07-01
- ModerateCorlanor ivabradine tablets recalled for presence of foreign substance
FDA (Drugs) · 2026-07-01